FDAnews
www.fdanews.com/articles/158018-paladin-unveils-otc-onychomycosis-therapy

Paladin Unveils OTC Onychomycosis Therapy

August 20, 2013
Canadian specialty pharmaceutical company Paladin Labs has released Emtrix, a once-a-day topical treatment for nail fungus that shows no side effects and has no conflicts with other medications.
Pharmaceutical Business Review